Sana Biotechnology

Sana Biotechnology is a Seattle-based biopharmaceutical company focused on engineering cells to repair and control genes or replace missing and damaged cells to address the underlying causes of disease. Founded in early 2019, it has grown to over 350 employees across Seattle, Cambridge, and South San Francisco. The company is publicly traded and conducts research in cell and gene therapy.